Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Albuterol Sulfate, 2.5 Mg/3 mL (0.083%) Inhalation Solution
Sodium Chloride 0.9% Inhl 3Ml
Locations
1
United States
Nemours Children's Health
Orlando, Florida, United States
Start Date
July 8, 2022
Primary Completion Date
December 31, 2029
Completion Date
December 31, 2030
Last Updated
April 27, 2025
NCT07243652
NCT06788093
NCT04959734
NCT06177197
NCT06321133
NCT05909566
Lead Sponsor
Nemours Children's Clinic
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions